Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone micro-dosing detection study in healthy men
ACTRN12619001506189Phase 4Terminated
- Sponsor
- Sydney Local Health District
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of testosterone, sponsored by Sydney Local Health District. Primary endpoint: Composite biomarker profiling for testosterone micro-dosing detection. Started Dec 2019; status: terminated.
02
Drugs
testosterone
Beyond the preview
Go deeper on ACTRN12619001506189.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12619001506189.